French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long

BACKGROUND: Hepatitis C virus (HCV) elimination by 2030, as targeted by the World Health Organization (WHO), requires that 90% of people with chronic infection be diagnosed and 80% treated. We estimated the cascade of care (CoC) for chronic HCV infection in mainland France in 2011 and 2016, before a...

Descripción completa

Detalles Bibliográficos
Autores principales: Brouard, Cécile, Pillonel, Josiane, Boussac, Marjorie, de Lédinghen, Victor, Rachas, Antoine, Silvain, Christine, Lydié, Nathalie, Chevaliez, Stéphane, Pioche, Corinne, Durand, Julien, Lot, Florence, Delarocque-Astagneau, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559725/
https://www.ncbi.nlm.nih.gov/pubmed/33059617
http://dx.doi.org/10.1186/s12879-020-05478-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559725/
https://www.ncbi.nlm.nih.gov/pubmed/33059617
http://dx.doi.org/10.1186/s12879-020-05478-6

Ejemplares similares